Inventor · disambiguated record
Mahendra R. Patel
Also filed as: PATEL MAHENDRA · PATEL MAHENDRA R
32 granted patents·22 pending applications·244 citations·filing 1980–2025
96Inventor score
Files withPATEL MAHENDRA R8SANDOZ AG6NAVINTA LLC5Aprecia Pharmaceuticals LLC4GENEVA PHARMACEUTICALS INC4
Top patents by PatentIndex Score
54 records- 0194US9603930B2Liquid bendamustine formulationPATEL MAHENDRA R·Filed 2015·Granted Mar 28, 2017·9 cites·20 claims
- 0292US7939104B2Solubility of hydrophobic drugs with a compound having a carboxylic acid moietySANDOZ AG·Filed 2008·Granted May 10, 2011·51 cites·13 claims
- 0391US11383440B2Three-dimensional printing system and equipment assemblyAprecia Pharmaceuticals LLC·Filed 2018·Granted Jul 12, 2022·5 cites·16 claims
- 0489US11732964B2Lyophilization promoting elementNAVINTA III INC·Filed 2021·Granted Aug 22, 2023·5 cites·18 claims
- 0587US10869848B2Carmustine pharmaceutical compositionPATEL MAHENDRA R·Filed 2019·Granted Dec 22, 2020·2 cites·17 claims
- 0683US11278501B2Method and system for forming a dosage form within a packagingAprecia Pharmaceuticals LLC·Filed 2019·Granted Mar 22, 2022·4 cites·20 claims
- 0782US10342769B2Carmustine pharmaceutical compositionPATEL MAHENDRA R·Filed 2015·Granted Jul 9, 2019·3 cites·8 claims
- 0881US7727556B2Solubility of hydrophobic drugs with a compound having a carboxylic acid moietySANDOZ AG·Filed 2005·Granted Jun 1, 2010·3 cites·30 claims
- 0981US4505890AControlled release formulation and methodSQUIBB & SONS INC·Filed 1983·Granted Mar 19, 1985·47 cites·9 claims
- 1079US10016447B2Pharmaceutical composition having improved content uniformityINTAS PHARMACEUTICALS LTD·Filed 2015·Granted Jul 10, 2018·2 cites·10 claims
- 1178US12202196B2Three-dimensional printing system and equipment assemblyAprecia Pharmaceuticals LLC·Filed 2022·Granted Jan 21, 2025·0 cites·19 claims
- 1278US10085971B2Pharmaceutical solution of asenapine for sublingual or buccal usePATEL MAHENDRA R·Filed 2017·Granted Oct 2, 2018·2 cites·19 claims
- 1376US6693211B2Chemical processGENEVA PHARMACEUTICALS INC·Filed 2003·Granted Feb 17, 2004·13 cites·3 claims
- 1475US6201153B1Synthesis of midodrine HCI from a novel intermediate 1-(2′,5′-dimethoxyphenyl)-2-azidoethanoneGENEVA PHARMACEUTICALS INC·Filed 2000·Granted Mar 13, 2001·8 cites·8 claims
- 1571US8536305B2Processes for preparing a polypeptideRAY ANUP K·Filed 2007·Granted Sep 17, 2013·2 cites·17 claims
- 1670US9475891B2Process for the preparation of colesevelam hydrochloridePATEL MAHENDRA R·Filed 2014·Granted Oct 25, 2016·1 cites·19 claims
- 1769US8729229B2Processes for preparing a polypeptideRAY ANUP KUMAR·Filed 2010·Granted May 20, 2014·2 cites·20 claims
- 1868US4327080ANovel Bendroflumethiazide formulations and methodSQUIBB & SONS INC·Filed 1981·Granted Apr 27, 1982·27 cites·24 claims
- 1967US2024180935A1Solution formulation of cyclophosphamideNAVINTA LLC·Filed 2023·Application pending·0 cites
- 2065US6962924B2Salt and polymorphs of desloratadine hemifumarateSANDOZ AG·Filed 2003·Granted Nov 8, 2005·3 cites·21 claims
- 2164US2022183986A1Method and system for forming a dosage form within a packagingAprecia Pharmaceuticals LLC·Filed 2022·Application pending·0 cites
- 2263US2023143212A1Pharmaceutical Preparations Of Melatonin Suitable For Intranasal AdministrationNAVINTA LLC·Filed 2022·Application pending·0 cites
- 2362US6458957B1α,α-dibromo-α-chloro-acetophenones as synthonsGENEVA PHARMACEUTICALS INC·Filed 2000·Granted Oct 1, 2002·3 cites·7 claims
- 2462US2025009670A1Stable Solid Oral Formulation Of Tafamidis Or Pharmaceutically Acceptable Salt ThereofNAVINTA LLC·Filed 2024·Application pending·0 cites
- 2561US7297789B2Process of preparation of olanzapine form ISANDOZ AG·Filed 2003·Granted Nov 20, 2007·2 cites·18 claims
- 2656US11826466B2Bendamustine solution formulationsNAVINTA LLC·Filed 2020·Granted Nov 28, 2023·0 cites·19 claims
- 2754US2015087681A1Bendamustine HCL Stable Lyophilized FormulationsPATEL PRANAV·Filed 2014·Application pending·0 cites
- 2853US2008188465A1Process of Preparation of Olanzapine Form IPATEL HIREN V·Filed 2007·Application pending·0 cites
- 2951US2006154862A1Processes for preparing a polypeptideRAY ANUP K·Filed 2005·Application pending·0 cites
- 3050US10456418B2Preparation of pharmaceutical dosage forms containing iron (III) saltsPATEL MAHENDRA R·Filed 2016·Granted Oct 29, 2019·0 cites·13 claims
- 3149US10905677B2Bendamustine solution formulationsPATEL MAHENDRA R·Filed 2017·Granted Feb 2, 2021·0 cites·11 claims
- 3249US2023330026A1Large Fast Dispersing Tablet Prepared By LyophilizationNAVINTA III INC·Filed 2021·Application pending·0 cites
- 3349US2003236285A1Stabilized pharmaceutical compositions containing benzimidazole compoundsFiled 2003·Application pending·0 cites
- 3448US7834176B2Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form ESANDOZ AG·Filed 2006·Granted Nov 16, 2010·0 cites·27 claims
- 3548US2025248977A1Tablet Formulation Of Tafamidis Or Pharmaceutically Acceptable Salt ThereofNAVINTA LLC·Filed 2025·Application pending·0 cites
- 3647US2003228363A1Stabilized pharmaceutical compositons containing benzimidazole compoundsFiled 2002·Application pending·0 cites
- 3745US6586598B2α, α-dibromo-α-chloro-acetophenones as synthonsGENEVA PHARMACEUTICALS INC·Filed 2002·Granted Jul 1, 2003·0 cites·15 claims
- 3845US4304773ANovel bendroflumethiazide formulations and methodSQUIBB & SONS INC·Filed 1980·Granted Dec 8, 1981·9 cites·10 claims
- 3945US2005095287A1Fosinopril compositionFiled 2004·Application pending·0 cites
- 4045US2010234566A1Processes for Preparing a PolypeptideRAY ANUP KUMAR·Filed 2010·Application pending·0 cites
- 4145US2010174048A1Processes for Preparing a PolypeptideRAY ANUP KUMAR·Filed 2010·Application pending·0 cites
- 4242US5587377ATerazosin crystalline polymorph and pharmaceutical compositions thereofINVAMED INC·Filed 1995·Granted Dec 24, 1996·9 cites·3 claims
- 4341US5872128AStabilized composition of ticlopidine hydrochlorideINVAMED INC·Filed 1997·Granted Feb 16, 1999·12 cites·17 claims
- 4440US2016243034A1Pharmaceutical composition comprising capecitabine and cyclophosphamideINTAS PHARMACEUTICALS LTD·Filed 2014·Application pending·0 cites
- 4540US2013115253A1Sustained Release Suspension Preparation For DextromethorphanPATEL MAHENDRA R·Filed 2012·Application pending·0 cites
- 4640US2019142755A1Tablet-in-tablet pharmaceutical composition comprising cyclophosphamide and capecitabineINTAS PHARMACEUTICALS LTD·Filed 2017·Application pending·0 cites
- 4739US5756124AMulti-scored pharmaceutical tabletsINVAMED INC·Filed 1996·Granted May 26, 1998·20 cites·7 claims
- 4839US2004213847A1Delayed release pharmaceutical compositions containing proton pump inhibitorsFiled 2003·Application pending·0 cites
- 4939US2003021841A1Pharmaceutical compositionFiled 2002·Application pending·0 cites
- 5038US10064826B2Direct compression and dry granulation processes for preparing carglumic acid tablets having less impurities than those produced by wet granulation processKAWALE SANJAY RANGNATHRAO·Filed 2014·Granted Sep 4, 2018·0 cites·9 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mahendra R. Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →